Web Analytics

3 Latest Announced Rounds

$1,325.73M Raised in 74 Funding Rounds in the past 7 Days - View All

Funding Round Profile

Inspire Biotherapeutics Inc

start up
Canada - Toronto, Ontario
  • 17/03/2023
  • Pre-Seed
  • Undisclosed Amount

Inspire has developed a lung tropic AAV gene therapy platform that has demonstrated transduction and long-term expression in lung tissue without impact on other tissue types in disease-relevant animal models. We are currently pursing initiation of a Proof-of-Concept clinical trial for a lethal neonatal lung disease with short time to data readout and success of therapy. The platform can then be applied to Cystic Fibrosis and other monogenic lung diseases.


Related People

Sandra DonaldsonFounder

Sandra Donaldson Canada - Toronto, Ontario

VP & COO OIRM. CEO & COO, Inspire Biotherapeutics. Experienced executive with a demonstrated history of nurturing research networks into thriving ecosystems while working in biotechnology and clinical trial sectors.